Outcomes of 596 Advanced Gastric Cancer Patients with Different Numbers of Chemotherapy Lines: The More Chemotherapy Lines, the Better Survival

OBJECTIVE: Many large-sample prospective randomized clinical trials investigating advanced gastric cancer (AGC) have confirmed the survival advantages of first-line, second-line, or third-line chemotherapy compared with their respective control groups. However, due to the ethical concerns of prospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Li, Wang, Huijun, Liu, Zhen, Meng, Ying, Qiu, Meiqing, Ju, Yafei, Zhang, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602914/
https://www.ncbi.nlm.nih.gov/pubmed/33149671
http://dx.doi.org/10.2147/CMAR.S275990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602914/
https://www.ncbi.nlm.nih.gov/pubmed/33149671
http://dx.doi.org/10.2147/CMAR.S275990

Ejemplares similares